Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05743465
Status:
COMPLETED
Last Update Posted:
2023-03-02
First Post:
2023-02-14
Brief Title:
A Study to Evaluate Available Treatment Information of Ponatinib Bosutinib Imatinib Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
Sponsor:
Takeda
Organization:
Takeda
Organization Data
Organization:
Takeda
Class:
INDUSTRY
Study ID:
GOR-2017-102256
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Takeda
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None